Iron metabolism after application of modified magnetite nanoparticles in rats

Biochemistry (Moscow)

Volumn 79, Issue 11, 2014, Pages 1245-1254

  Milto, I V ^a,b   Grishanova, A Yu ^c   Klimenteva, T K ^a   Suhodolo, I V ^a   Vasukov, G Yu ^a   Ivanova, V V ^a  

^a SIBERIAN STATE MEDICAL UNIVERSITY   (Russian Federation)

^b NATIONAL RESEARCH TOMSK POLYTECHNIC UNIVERSITY   (Russian Federation)

^c INSTITUTE OF MOLECULAR BIOLOGY AND BIOPHYSICS   (Russian Federation)

Author keywords

Ceruloplasmin; Chitosan modified nanomagnetite; Ferritin; Magnetoliposomes; Nanomagnetite; Transferrin

Indexed keywords

RATTUS;

IRON; MAGNETITE NANOPARTICLE;

ANIMAL; ATOMIC ABSORPTION SPECTROMETRY; BLOOD; KIDNEY; LIVER; LUNG; MALE; METABOLISM; RAT; SPECTROMETRY; SPLEEN; TISSUE DISTRIBUTION; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANIMALS; IRON; KIDNEY; LIVER; LUNG; MAGNETITE NANOPARTICLES; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; RATS; SPECTROMETRY, X-RAY EMISSION; SPECTROPHOTOMETRY, ATOMIC; SPLEEN; TISSUE DISTRIBUTION;

EID: 84919633265     PISSN: 00062979     EISSN: 16083040     Source Type: Journal    
DOI: 10.1134/S0006297914110121     Document Type: Article

References (28)

1. Milto, I. V., Klimenteva, T. K., Suhodolo, I. V., and Krivova, N. A. (2013) Pro- and antioxidant activity of blood plasma and histology of internal organs of rats after intravenous infusion of nanoparticles, Biomed. Khim., 3, 330-338.
2. Nel, A., Xia, T., and Madler, L. (2006) Toxic potential of materials at the nano-level, Science, 311, 622-627.
3. Ito, A., Shinkai, M., Honda, H., and Kobayashi, T. (2005) Medical application of functionalized magnetic nanoparticles, J. Biosci. Bioeng., 1, 1-11.
4. Borm, P. J. A., Robbins, D., Haubold, S., Kuhlbusch, T., Fissan, H., Donaldson, K., Schins, R., Stone, V., Kreyling, W., Lademann, J., Krutmann, J., Warheit, D., and Oberdorster, E. (2006) The potential risks of nanomaterials, Particle Fibre Toxicol., 3, 611-646.
5. Milto, I. V., Suhodolo, I. V., and Usov, V. Yu. (2012) Mononuclear phagocytes of rat liver and lung after intravenous infusion of the suspension of magnetite nanoparticles, Tsitologiya, 7, 566-572.
6. Hanini, A., Schmitt, A., Kacem, K., Chau, F., Ammar, S., and Gavard, J. (2011) Evaluation of iron oxide nanoparticle biocompatibility, Int. J. Nanomed., 6, 787-794.
7. Babadi, V. Y., Najafi, L., Najafi, A., Gholami, H., Ebrahim, M., Zarji, B., Golzadeh, J., Amraie, E., and Shirband, A. (2012) Evaluation of iron oxide nanoparticles effects on tissue and enzymes of liver in rats, J. Pharm. Biomed. Sci., 23, 4-4.
8. Berry, C. C., and Curtis, A. S. G. (2003) Functionalization of magnetic nanoparticles for applications in biomedicine, J. Phys. D: Appl. Phys., 36, R198-R206.
9. Rosi, N. L., and Mirkin, C. A. (2005) Nanostructures in biodiagnostics, Chem. Rev., 4, 1547-1562.
10. Okon, E., Pouliquen, D., Okon, P., Kovaleva, Z. V., Stepanova, T. P., Lavit, S. G., Kudryavtsev, B. N., and Jallet, P. (1994) Biodegradation of magnetite dextran nanoparticles is in the rat: a histological and biophysical study, Lab. Invest., 71, 895-903.
11. Nayden, E. P., Itin, V. I., Magayeva, A. A., and Terekhova, O. G. (2009) The effect of aging on phase composition, structure, and magnetic properties of nanosized powders of oxide ferrimagnetics, Fiz. Tverdogo Tela, 51, 1576-1579.
12. Terekhova, O. G., Itin, V. I., Magayeva, A. A., Nayden, E. P., Ivanov, Yu. F., Maksimov, Yu. M., and Boldyrev, V. V. (2008) Mechanochemical synthesis of nanosized ferrite powders from saline systems, Izv. VUZov: Poroshkov. Metallurg. Funkts. Pokrytiya, 1, 45-50.
13. Tazina, E. V. (2010) Development and Biopharmaceutical Substantiation of the Thermosensitive Liposomal Doxorubicin: Candidate's dissertation [in Russian], Blokhin Russian Oncological Research Center, Moscow.
14. Kazyukova, T. V., Levina, A. A., Tsvetaeva, N. V., Mamukova, Yu. I., and Tsybul'skaya, M. M. (2006) Regulation of iron metabolism, Pediatriya, 6, 94-99.
15. Salata, O. V. (2004) Applications of nanoparticles in biology and medicine, J. Nanobiotechnol., 2, 120-127.
16. Weissleder, R., Stark, D. D., Engelstad, B. L., Bacon, B. R., Compton, C. C., White, D. L., Jacobs, P., and Lewis, J. (1989) Superparamagnetic iron oxide: pharmacokinetics and toxicity, Am. J. Rentgenol., 152, 167-173.
17. Gupta, A. K., Naregalkar, R. R., Vaidya, V. D., and Gupta, M. (2007) Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications, Nanomedicine, 2, 23-39.
18. Nishimura, K., Ishihara, C., Ukei, S., Tokura, S., and Azuma, I. (1986) Stimulation of cytokine production in mice using deacetylated chitin, Vaccine, 4, 151-156.
19. Duguet, E., Vasseur, S., Mornet, S., and Devoisselle, J.-M. (2006) Magnetic nanoparticles and their applications in medicine, Nanomedicine, 1, 157-168.
20. Chouly, C., Pouliquen, D., Lucet, I., Jeune, J. J., and Jallet, P. (1996) Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution, J. Microencapsul., 13, 245-255.
21. Bourrinet, P., Bengele, H. H., Bonnemain, B., Dencausse, A., Idee, J. M., and Jacobs, P. M. J. M. (2006) Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent, Invest. Radiol., 41, 313-324.
22. Hanini, A., Schmitt, A., Kacem, K., Chau, F., Ammar, S., and Gavard, J. (2011) Evaluation of iron oxide nanoparticle biocompatibility, Int. J. Nanomed., 6, 787-794.
23. Lemarchand, C., Gref, R., and Couvreur, P. (2004) Polysaccharide-decorated nanoparticles, Europ. J. Pharm. Biopharm., 58, 327-341.
24. Andrews, N. C., and Schmidt, P. J. (2007) Iron homeostasis, Annu. Rev. Physiol., 69, 69-85.
25. Milto, I. V., and Suhodolo, I. V. (2012) Structural changes in some organs of rats after a single intravenous infusion of nanosized magnetite, Morfologiya, 2, 49-53.
26. Kim, J. S., Yoon, T. J., Yu, K. N., Kim, B. G., Park, S. J., Kim, H. W., Lee, K. H., Park, S. B., Lee, J. K., and Cho, M. H. (2006) Toxicity and tissue distribution of magnetic nanoparticles in mice, Toxicol. Sci., 89, 338-347.
27. Lapin, A. (2002) Soluble transferrin receptor: novel parameter for determining status of iron, Lab. Med., 5, 9-13.
28. Briley-Saebo, K., Bjomerud, A., Grant, D., Ahlstrom, H., Berg, T., and Kindberg, G. M. (2004) Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging, Cell Tissue Res., 316, 315-323.